Suchergebnisse - "Toshner, Mark"

PubPharm (183)

21

CTEPH has shared and distinct genetic associations with pulmonary embolism in a genome-wide association study

enthalten in: bioRxiv.org | 2023

von Liley, J. | Newnham, M. | Bleda, M. | +20

22

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

enthalten in: Giornale italiano di cardiologia (2006) | 2023

von Humbert, M. | Kovacs, G. | Hoeper, M. | +27

23

Highlights from the International Chronic Thromboembolic Pulmonary Hypertension Congress 2021

enthalten in: European respiratory review : an official journal of the European Respiratory Society | 2023

von Simonneau, G. | Fadel, E. | Vonk Noordegraaf, A. | +20

24

Angiopoietin 2 and hsCRP are associated with pulmonary hemodynamics and long-term mortality respectively in CTEPH-Results from a prospective discovery and validation biomarker study

enthalten in: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation | 2023

von Hadinnapola, C. | Southwood, M. | Hernández-Sánchez, J. | +12

25

Human Cytomegalovirus Infection of Epithelial Cells Increases SARS-CoV-2 Superinfection by Upregulating the ACE2 Receptor

enthalten in: The Journal of infectious diseases | 2023

von Perera, M. | Greenwood, E. | Crozier, T. | +107

26

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

enthalten in: The European respiratory journal | 2023

von Humbert, M. | Kovacs, G. | Hoeper, M. | +27

CommentIn: Eur Respir J. 2023 Jan 6;61(1):. - PMID 36609524

27

Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection

enthalten in: Nature medicine | 2023

von Mentzer, A. | O'Connor, D. | Bibi, S. | +67

28

Characteristics and risk factors for post-COVID-19 breathlessness after hospitalisation for COVID-19

enthalten in: ERJ open research | 2023

von Daines, L. | Zheng, B. | Elneima, O. | +30

29

Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups

enthalten in: Frontiers in immunology | 2023

von Hurler, L. | Szilágyi, �. | Mescia, F. | +126

30

Apixaban following discharge in hospitalised adults with COVID-19: Preliminary results from a multicentre, open-label, randomised controlled platform clinical trial

enthalten in: bioRxiv.org | 2022

von Toshner, M. | Gamble, C. | Baillie, J. | +18